Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Growth Paris  >  Crossject SA    ALCJ   FR0011716265

CROSSJECT SA

(ALCJ)
  Report
End-of-day quote. End-of-day quote Euronext Growth Paris - 12/01
3.795 EUR   +5.42%
09/21CROSSJECT : Update on the group's business
AL
09/21CROSSJECT : First-half 2020 results and business update
PU
09/18CROSSJECT SA : Half-year results
CO
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Euronext Growth Paris
11/25/2020 11/26/2020 11/27/2020 11/30/2020 Date
3.555(c) 3.55(c) 3.485(c) 3.6(c) 3.795 Last
1 117 289 638 351 246 910 386 653 238 080 Volume
+6.76% -0.14% -1.83% +3.30% +5.42% Change
More quotes
Financials
Sales 2020 0,04 M 0,04 M 0,04 M
Net income 2020 - - -
Net Debt 2020 19,7 M 23,6 M 23,6 M
P/E ratio 2020 -6,20x
Yield 2020 -
Sales 2021 1,76 M 2,10 M 2,10 M
Net income 2021 - - -
Net Debt 2021 19,7 M 23,6 M 23,6 M
P/E ratio 2021 161x
Yield 2021 -
Capitalization 91,3 M 109 M 109 M
EV / Sales 2020 3 110x
EV / Sales 2021 63,2x
Nbr of Employees 88
Free-Float 80,7%
More Financials
Company
Crossject SA specializes in manufacturing and marketing needleless drug self-injection. The group provides Zeneo, a prefilled and single-use device that can be used for intradermal, subcutaneous and intramuscular injections. 
More about the company
All news about CROSSJECT SA
09/21CROSSJECT : Update on the group's business
AL
09/21CROSSJECT : First-half 2020 results and business update
PU
09/18CROSSJECT SA : Half-year results
CO
09/04CROSSJECT : appoints Don Zinn as VP US Business
PU
07/07CROSSJECT : Result of votes at Combined General Meeting of 25 june 2020
PU
07/07CROSSJECT : End of the conversion of convertible bonds in 2019
PU
05/22No major changes after the release of the FY19 report (Crossject)
AL
03/29Meaningless FY19 results and product update (Crossject)
AL
03/28CROSSJECT : 2019 annual results and business update
PU
02/18CROSSJECT : Information relative au nombre total de droits de vote et d'actions ..
GL
01/29CROSSJECT : Information relative au nombre de droits de vote et d'actions compos..
GL
2019CROSSJECT SA : Annual Report
CO
2019Extra-financing to increase visibility (Crossject)
AL
2019A €2.6m non-dilutive issue (Crossject)
AL
2019Cooperation agreement with the US Department of Defense (Crossject)
AL
More news
News in other languages on CROSSJECT SA
10/30CROSSJECT : Rapport financier semestriel 2020
10/13CROSSJECT : Invest Securities relève son objectif
09/21CROSSJECT : Point sur le développement de la société
09/21Les valeurs à suivre aujourd'hui à la Bourse de Paris Lundi 21 septembre 2020
09/21Quand la banque européenne s'éveillera...
More news
Analyst Recommendations on CROSSJECT SA
More recommendations
Chart CROSSJECT SA
Duration : Period :
Crossject SA Technical Analysis Chart | ALCJ | FR0011716265 | MarketScreener
Technical analysis trends CROSSJECT SA
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 1
Average target price 1,20 €
Last Close Price 3,60 €
Spread / Highest target -66,7%
Spread / Average Target -66,7%
Spread / Lowest Target -66,7%
EPS Revisions
Managers
NameTitle
Patrick Alexandre Chairman-Executive Board & Chief Executive Officer
Philippe Monnot Chairman-Supervisory Board
Eric Nemeth Member-Supervisory Board
Patrice Coissac Member-Supervisory Board
Jean-Francois Loumeau Member-Supervisory board
Sector and Competitors
1st jan.Capitalization (M$)
CROSSJECT SA56.52%109
ABBOTT LABORATORIES24.59%191 805
MEDTRONIC PLC0.22%152 480
STRYKER CORPORATION11.17%87 710
BECTON, DICKINSON AND COMPANY-13.65%68 111
HOYA CORPORATION33.11%49 894